FIELD: medicine, pharmacology.
SUBSTANCE: invention concerns chemical-pharmaceutical industry, namely to creation of the agent possessing selective radio- and chemoprotective action on damaged normal tissues. The agent contains a denaturated, emulsified, disharmonic placenta, i.e. without an admixture of hormones, and also hyaluronic acid, natural honey, natural olive oil and starch potato in the parities providing expressed selective therapeutic effect. The agent does not cause toxic reactions, possesses ability to stimulate hemopoiesis by augmentation of a pool of precursor cells.
EFFECT: creation of agent possessing selective radio- and chemoprotective action on damaged normal tissues which possesses ability to stimulate hemopoiesis by augmentation of pool of precursor cells.
4 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PROTECTING ANIMALS FROM HIGH-DOSE IONIZING RADIATION | 2019 |
|
RU2701155C1 |
METHOD OF APPLYING VEGETABLE POLYSACCHARIDE AS RADIOPROTECTOR AND STIMULATOR OF COLONY FORMATION OF SPLEEN STEM CELLS IN IRRADIATED ANIMALS | 2013 |
|
RU2537033C1 |
HEMATOPOIETIC PRECURSOR CELL DIFFERENTIATION INHIBITOR | 2006 |
|
RU2317074C1 |
RADIOPROTECTOR | 2010 |
|
RU2428192C1 |
RADIOLOGICAL PROTECTION AGENT | 1992 |
|
RU2049469C1 |
AGENT FOR PREVENTION OF ACUTE RADIATION DISEASE | 2015 |
|
RU2599844C1 |
METHOD OF PHARMACOLOGICAL PROTECTION FROM IONIZING RADIATION | 2017 |
|
RU2663465C1 |
RADIO-PROTECTING DEVICE | 1996 |
|
RU2144357C1 |
METHOD OF COMBINED THERAPY FOR CONNECTIVE TISSUE SARCOMA M-1 IN RATS USING A CONJUGATE OF DIPROPOXYBACTERIOPURPURIN WITH DOXORUBICIN | 2023 |
|
RU2808909C1 |
MEANS OF SIMULTANEOUS PROTECTIVE ACTION IN RELATION TO HEALTHY ORGANS AND TISSUE AND ADJUVANT ACTION IN RADIO AND CHEMOTHERAPY OF TUMOURS | 2015 |
|
RU2646497C2 |
Authors
Dates
2008-11-27—Published
2007-03-16—Filed